A GOG 210 ACGH study of gain at 1q23 in endometrioid endometrial cancer in the context of racial disparity and outcome

Genes Chromosomes and Cancer

Volumn 49, Issue 9, 2010, Pages 791-802

  Morrison, Carl ^a   Miecznikowski, Jeffrey ^a,b   Darcy, Kathleen M ^a   Dolce, Jean M ^a   Kandel, Eugene ^a   Erwin, Deborah O ^a   Liu, Song ^b   Shepherd, Lori ^b   Cohn, David ^c   McMeekin, D Scott ^d   Block, AnneMarie W ^a   Nowak, Norma J ^a,b   Maxwell, Larry ^e  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^e WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CHROMOSOME 1Q; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE SEVERITY; ENDOMETRIOID CARCINOMA; EUROPEAN AMERICAN; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FROZEN SECTION; GENE DOSAGE; GENE LOCUS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RACE DIFFERENCE; VALIDATION STUDY; ADENOCARCINOMA, CLEAR CELL; CARCINOMA, ENDOMETRIOID; CAUCASIAN; CHROMOSOME 1; COMPARATIVE STUDY; CYSTADENOCARCINOMA, SEROUS; ENDOMETRIAL NEOPLASMS; ETHNOLOGY; GENE AMPLIFICATION; GENETICS; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME;

ADENOCARCINOMA, CLEAR CELL; AFRICAN AMERICANS; CARCINOMA, ENDOMETRIOID; CHROMOSOMES, HUMAN, PAIR 1; COMPARATIVE GENOMIC HYBRIDIZATION; CYSTADENOCARCINOMA, SEROUS; ENDOMETRIAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77955493270     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20782     Document Type: Article

References (29)

1. Allard JE, Maxwell GL. 2009. Race disparities between black and white women in the incidence, treatment, and prognosis of endometrial cancer. Cancer Control 16:53-56.
2. Argani P, Antonescu CR, Couturier J, Fournet JC, Sciot R, Debiec-Rychter M, Hutchinson B, Reuter VE, Boccon-Gibod L, Timmons C, Hafez N, Ladanyi M. 2002. PRCC-TFE3 renal carcinomas: Morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am J Surg Pathol 26:1553-1566. (Pubitemid 35387219)
3. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate - A practical and powerful approach to multiple testing. J R Stat Soc B 57:289-300.
4. Brzeziańska E, Pastuszak-Lewandoska D, Lewiński A. 2007. Rearrangements of NTRK1 oncogene in papillary thyroid carcinoma. Neuro Endocrinol Lett 28:221-229. (Pubitemid 47045763)
5. Coates RJ, Click LA, Harlan LC, Robboy S, Barrett RJ, II, Eley JW, Reynolds P, Chen VW, Darity WA, Blacklow RS, Edwards BK. 1996. Differences between black and white patients with cancer of the uterine corpus in interval from symptom recognition to initial medical consultation (United States). Cancer Causes Control 7:328-336.
6. Connell PP, Rotmensch J, Waggoner SE, Mundt AJ. 1999. Race and clinical outcome in endometrial carcinoma. Obstet Gynecol 94:713-720. (Pubitemid 29484437)
7. Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, Friedman C, Harlan L, Warren J, Anderson RN, Pickle LW. 2005. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97:1407-1427.
8. Farley J, Risinger JI, Rose GS, Maxwell GL. 2007. Racial disparities in blacks with gynecologic cancers. Cancer 110:234-243. (Pubitemid 47121882)
9. Ferguson SE, Olshen AB, Levine DA, Viale A, Barakat RR, Boyd J. 2006. Molecular profiling of endometrial cancers from African-American and Caucasian women. Gynecol Oncol 101:209-213.
10. Hicks ML, Phillips JL, Parham G, Andrews N, Jones WB, Shingleton HM, Menck HR. 1998. The national cancer data base report on endometrial carcinoma in African-American women. Cancer 83:2629-2637.
11. Hill HA, Coates RJ, Austin H, Correa P, Robboy SJ, Chen V, Click LA, Barrett RJ, II, Boyce JG, Kotz HL. 1995. Racial differences in tumor grade among women with endometrial cancer. Gynecol Oncol 56:154-163.
12. Indo Y, Mardy S, Miura Y, Moosa A, Ismail EAR, Toscano E, Andria G, Pavone V, Brown DL, Brooks A, Endo F, Matsuda I. 2001. Congenital insensitivity to pain with anhidrosis (CIPA): novel mutations of the TRKA (NTRK1) gene, a putative uniparental disomy, and a linkage of the mutant TRKA and PKLR genes in a family with CIPA and pyruvate kinase deficiency. Hum Mutat 18:308-318.
13. Kohler MF, Berchuck A, Davidoff AM, Humphrey PA, Dodge RK, Iglehart JD, Soper JT, Clarke-Pearson DL, Bast RC, Jr, Marks JR. 1992. Overexpression and mutation of p53 in endometrial carcinoma. Cancer Res 52:1622-1627.
14. Liu R, Conaway M, Rodriguez GC, Soper JT, Clarke-Pearson DL, Berchuck A. 1995. Relationship between race and interval to treatment in endometrial cancer. Obstet Gynecol 86:486-490.
15. Maxwell GL, Risinger JI, Hayes KA, Alvarez AA, Dodge RK, Barrett JC, Berchuck A. 2000. Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers. Clin Cancer Res 6:2999-3005.
16. Maxwell GL, Tian C, Risinger J, Brown CL, Rose GS, Thigpen JT, Fleming GF, Gallion HH, Brewster WR. 2006. Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma: A gynecologic oncology group study. Cancer 107:2197-2205. (Pubitemid 44665654)
17. Miecznikowski JC, Gaile DP, Conroy JM, Nowak NJ. 2007. aCGH Normalizing Algorithm. Technical Report 0607. Buffalo, NY: Department of Biostatistics, University at Buffalo.
18. Mitelman F. 1984. Restricted number of chromosomal regions implicated in the aetiology of human cancer and leukaemia. Nature 310:325-327. (Pubitemid 14098666)
19. Mitelman F. 1986. Clustering of breakpoints to specific chromosomal regions in human neoplasia. A survey of 5345 cases. Hereditas 104:113-119.
20. Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer. 2010. Mitelman F, Johansson B, Mertens F (Eds.), http://cgap.nci.nih.gov/ Chromosomes/Mitelman
21. Nowak NJ, Gaile D, Conroy JM, McQuaid D, Cowell J, Carter R, Goggins MG, Hruban RH, Maitra A. 2005a. Genome wide aberrations in pancreatic adenocarcinoma. Cancer Genet Cytogenet 161:36-50.
22. Nowak NJ, Snijders A, Conroy J, Albertson D. 2005b. The BAC Resources. Current Protocols in Human Genetics. New York: Wiley, Unit 4.13.
23. Olshen A, Venkatraman ES, Lucito R, Wigler M. 2004. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5:557-572. (Pubitemid 41180205)
24. Powell MA, Mutch DG, Rader JS, Herzog TJ, Huang TH, Goodfellow PJ. 2002. Ribosomal DNA methylation in patients with endometrial carcinoma: An independent prognostic marker. Cancer 94:2941-2952.
25. Randall TC, Armstrong K. 2003. Differences in treatment and outcome between African-American and white women with endometrial cancer. J Clin Oncol 21:4200-4206. (Pubitemid 46606189)
26. R Development Core Team. 2007. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing. ISBN 3-900051-07-0. URL: http://www.R-project.org.
27. Santin AD, Bellone S, Siegel ER, Palmieri M, Thomas M, Cannon MJ, Kay HH, Roman JJ, Burnett A, Pecorelli S. 2005. Racial differences in the over-expression of epidermal growth factor type II receptor (HER2/neu): A majorprognostic indicator in uterine serous papillary cancer. Am J Obstet Gynecol 192:813-818.
28. Sidhar SK, Clark J, Gill S, Hamoudi R, Crew,AJ, Gwilliam R, Ross M, Linehan WM, Birdsall S, Shipley J, Cooper CS. 1996. The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Mol Genet 5:1333-1338.
29. Watson SK, deLeeuw RJ, Horsman DE, Squire JA, Lam WL. 2007. Cytogenetically balanced translocations are associated with focal copy number alterations. Hum Genet 120:795-805.